Introduction and Context
Hospitals increasingly encounter patients who manage diabetes with continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery (AID) systems. These technologies—once confined to outpatient care—offer real‑time glycemic data and precise insulin delivery that can improve glucose control. But their inpatient use raises clinical, operational, safety, and legal questions: when can devices be continued, when should they be stopped, how should staff interpret CGM metrics in the hospital setting, and how should data be integrated into electronic health records (EHRs)?
